Not Signed In - New Analyses From Phase 3 Trial In CLL Identify Relapsed Patients Who Maximally Benefit From Genasense(R) Treatment
Thu, 09 Nov 2006 08:00 AM EST
... Genta Incorporated (Nasdaq: GNTA) announced the presentation of new analyses from the Company's randomized Phase 3 trial of Genasense(R) (oblimersen sodium) Injection in patients with relapsed or refractory chronic lymphocytic leukemia (CLL). [click link for full article] ...
Related Topics
- Clinical Trials
- Cll
- Food Recommendations: South Beach Diet - Phase 1
- Food Recommendations: South Beach Diet - Phase 2
- Chronic lymphocytic leukemia (CLL)
- Seizures (in about half of patients)
- What Your Female Patients Want to Know About Bladder Control
- Vaccinations For HIV/AIDs Patients
- Smoking Cessation and Continued Risk in Cancer Patients
- Treatment
- Approximately one-half of patients with small tumors will get back useful hearing in the affected ear after surgery.
- Treatments
- Spider Bites
- Pension
- Pancreatic Cancer
- Chronic Lymphocytic Leukemia
- Leukemia, Chronic Lymphocytic
- Most people with small tumors will have no permanent paralysis of the face after surgery. However, about two-thirds of patients with large tumors will have some permanent facial weakness after surgery.
- Turmeric
- Lecithin
email this page
print this page
bookmark this page
feedback on this page
